Oxurion to Participate in Upcoming Investor Conferences
apnews.com
science
2022-06-01 17:18:06

Leuven, BELGIUM, Boston, MA, US – June 1, 2022 – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, announced today that Michael Dillen, Chief Business Officer, will participate in two investor conferences in June.BIO International2022 June 13-14, 2022 | San Diego, CA
